Circulating Tumour DNA for Minimal Residual Disease: Assay Sensitivity and the Decisions It Cannot Yet Support. Translational Medicine & Therapeutics Journal, [S. l.], v. 2, n. 2, p. 110–119, 2023. DOI: 10.5281/zenodo.22649122. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/89. Acesso em: 5 nov. 2026.